Navigation Links
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
Date:6/11/2009

ted with the greatest remaining burden of invasive disease. Both Prevenar 13 and Prevenar use CRM197 -- an immunological carrier protein with a 20-year history of use in pediatric vaccines.

Phase 3 Data Results

Data from the studies presented at ESPID indicate that Prevenar 13 is immunogenic for all serotypes and showed a safety profile similar to Prevenar. Among the study findings:

  • In a study conducted in France, 613 children were randomized to receive either four doses of Prevenar or Prevenar 13 at 2, 3, 4 and 12 months, or three doses of Prevenar at 2, 3 and 4 months with a booster dose of Prevenar 13 or Prevenar at 12 months. Antibody response was measured at month 13. Both of the Prevenar 13 schedules induced a robust immune response for all 13 serotypes.
  • In a study conducted in Italy, 606 healthy infants aged 3 months were randomized to receive Prevenar 13 or Prevenar along with Infanrix hexa(R) [GlaxoSmithKline], the combined diphtheria, tetanus, pertussis, hepatitis B, inactivated poliovirus, and Hib vaccine, at 3, 5, and 11 months of age. Assessment of functional antibody levels (serotype specific opsonphagocytic assay) one month after the infant series and after the booster dose showed that a high percentage of infants receiving Prevenar 13 had functional antibodies for all serotypes. Prevenar 13 did not affect responses to the concomitantly administered vaccine and showed a safety profile comparable to Prevenar.
  • A study of 352 children in Poland assessed the safety and immunogenicity of Prevenar 13 in older children not previously immunized with Prevenar. Children were vaccinated with one of three different catch-up schedules currently recommended for Prevenar. These treatment schedules included the following: 1) two doses of Prevenar 13 at age 7 to <12 months with a booster at age 12-16 months; 2) two doses of Prevenar 13 at age 12 to
    '/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
6. Phase III Trial Finds Pharmaxis Bronchitol Effective
7. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
8. YM BIOSCIENCES ANNOUNCES POSITIVE PRELIMINARY RESULTS FROM PHASE I/II LUNG CANCER TRIAL OF NIMOTUZUMAB COMBINED WITH RADIATION
9. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
10. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
11. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
(Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... class-action lawsuit on behalf of Wisconsin consumers against Microsoft ... result of last week's state Supreme Court ruling ... Olstad, seeks a settlement fund for all Wisconsin consumers ... contention is that Wisconsin consumers have paid inflated prices ...
... Wis. - When Hurricane Dennis reached landfall in ... not too surprising a development. Weather Central Inc. ... already forecast almost the exact location two days earlier. ... forecast model, a service used by more than 100 ...
... SecurePipe , a provider of managed network security ... acquire the assets of Mycom's mailMAX Managed ... Cincinnati-based Mycom Group, Inc. , ,SecurePipe is a provider ... manufacturing, education, health care and financial institutions. Headquarted in ...
Cached Biology Technology:Wisconsin Supreme Court rules against Microsoft 2
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... Iowa biologist Daniel Eberl and his colleagues have shown that one ... in your car. And if that isn,t interesting enough, the ... similar auditory system in fruit fliesand by making use of the ... hearing resembles a battery, you need to know that the auditory ...
... France, more than 860,000 people suffer from Alzheimer,s disease ... age-related loss of intellectual function. Cognitive impairments observed in ... proteins in nerve cells undergoing degeneration . We know ... of insulin resistance and type 2 diabetes, increases the ...
... solving puzzles, animals in captivity are, well, different animals than ... problems has been historically conducted on animals in captivity. Only ... on animals in their natural habitat. In a study appearing ... University found vast differences in the problem solving skills between ...
Cached Biology News:UI researcher learns mechanism of hearing is similar to car battery 2Detrimental effect of obesity on lesions associated with Alzheimer's disease 2
... PCR carry-over contamination, which prevents false ... products from previous PCR amplifications without ... improves amplification ,Optimized for use with ... instrument systems , The GeneAmp PCR ...
... that catalyzes the hydrolysis of,starch to ... dextrins. The,level of a-amylase in various ... of,clinical significance in the diagnosis of ... and microbial a-amylases are,important enzymes for ...
... Labsystems Wellmix is a high-quality four-place microplate ... The shaking speed is adjustable from 100 ... speed and a small orbit ensure effective ... time is quick and easy to set ...
Rabbit polyclonal to STUB1 ( Abpromise for all tested applications). entrezGeneID: 10273 SwissProtID: Q9UNE7...
Biology Products: